2019
DOI: 10.1002/cbic.201800613
|View full text |Cite
|
Sign up to set email alerts
|

Pull‐Down of Metalloproteins in Their Native States by Using Desthiobiotin‐Based Probes

Abstract: One‐third of all proteins are estimated to require metals for structural stability and/or catalytic activity. Desthiobiotin probes containing metal binding groups can be used to capture metalloproteins with exposed active‐site metals under mild conditions so as to prevent changes in metallation state. The proof‐of‐concept was demonstrated with carbonic anhydrase (CA), an open active site, Zn2+‐containing protein. CA was targeted by using sulfonamide derivatives. Linkers of various lengths and structures were s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
1
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 42 publications
2
1
0
Order By: Relevance
“…Furthermore, the use of excess NT-Az (∼10 mol equiv) minimized the probability for multivalent interactions. The binding affinity of D-Bv to VEGF and NT-Az was similar to previously published K D ’s (Bv–VEGF, 10 –9 –10 –11 M; NT–desthiobiotin, 10 –11 –10 –13 M). ,, …”
Section: Resultssupporting
confidence: 87%
See 1 more Smart Citation
“…Furthermore, the use of excess NT-Az (∼10 mol equiv) minimized the probability for multivalent interactions. The binding affinity of D-Bv to VEGF and NT-Az was similar to previously published K D ’s (Bv–VEGF, 10 –9 –10 –11 M; NT–desthiobiotin, 10 –11 –10 –13 M). ,, …”
Section: Resultssupporting
confidence: 87%
“…The binding affinity of D-Bv to VEGF and NT-Az was similar to previously published K D 's (Bv− VEGF, 10 −9 −10 −11 M; NT−desthiobiotin, 10 −11 −10 −13 M). 25,27,28 Using CD16α modified surfaces for BLI detection, D-Bv showed concentration-dependent binding for CD16α (Figure 2D,E) with a calculated K D of 3.6 × 10 −7 M (Figure 2F) similar to previous reports for human IgG1s (7.2 × 10 −7 M). 29 Therefore, the retained binding affinity for targeting ligands and immune cell Fc surface receptors indicates that desthiobiotin modification of Abs is tolerable for cytokine or receptor blockade (e.g., antiangiogenesis, checkpoint inhibitors) and immune cell recruitment [e.g., antibody-dependent cellular toxicity (ADCC)].…”
Section: Resultssupporting
confidence: 86%
“…Alternatively, desthiobiotin, an analog of biotin which does not contain sulfur, can be used. Desthiobiotin has a lower affinity with avidin, therefore, the ABPs and enzymes can better tolerate the dissociation conditions ( Hirsch et al, 2002 ; Ngo et al, 2019 ).…”
Section: Introductionmentioning
confidence: 99%